Growth intact, margins compressed—rate cycle proof needed

Cost of funds remained flat at 4.4%; FCNR mix offset repricing gains

Growth reported at 18.8% YoY; FCNR/special deposits ~1.3 trillion of 1.57 trillion growth

MSME growth 23.5% YoY reported vs 22.3% prior guidance

Retail disbursements 90k Cr Q2 vs 76k Cr Q1; +18.4% QoQ

Margins compressed (3.32%), rate repricing started October but full benefit only Q3+ ; claim credible but unproven

Q1 guidance: improve 40-50 bps. Q2 actual: flat at 4.4%. FCNR/mix offset repricing. Trajectory delayed to Q3.

Reaffirmed prior 'range-bound near-term' but now signals Q2 trough and Q3+ upside from rate cycle. Slightly more constructive.

Monsoon shortfall ~1.5–2%; sowing impact 3–5% variance expected. Agri book growth moderated to single-digit (healthy control).

CASA ratio target 38% unmet; household deposits shifting mix. Large one-off outflows this Q. Core liability growth slower ex-FCNR.

Building new customer engagement; deposits doubled over 5 years, maturing next 5. Agri sowing down 1.5–2%, output variance 3–5%; book growth moderated to single-digit.

Cost of funds flat at 4.4%; deposit growth ₹1.57 trillion (₹1.3 trillion time deposits) masks repricing. Corporate growth 2.8% Q-o-Q; YoY 16.4%. Back book relief 20–30% coming next 2 Q.

70% floating-rate book; 25 bps Oct repricing factors in by Dec. FCNR a headwind Q2; neutral-to-positive margin outlook as volumes grow. Trajectory upward from Q3.

Yes, Q2 may be bottom for margins; rate cycle kicked in October. Repo repriced 70% loans already. Should start improving Q3; directionally upward.

MCLR minuscule portion of book (~single digit %); cost to assets 1.73 low. Slippages improving across portfolios; credit environment benign.

CASA opportunity exists in 2–3 ppts lower-than-average branches in many markets. Household deposits available; retail CASA healthy in late 40s. Will explore non-deposit strategies; CASA ratio protected.

Staff stable 3 years; technology investments maturing. Productivity 10% CAGR headcount, 18–19% volumes; double-digit efficiency gains. More frontline hires expected, fewer back-end.

One-off outflows from large corporates masked strong momentum. Core deposits strong; exploring non-deposit strategies. Over next couple of quarters, expect thought process on mix from Anup.

Target LCR 110–120 (regulatory band). Branch deposits 80% of total; opportunistic CD replacement of large outflows. Draft insurance rules: commission rates high; aiming for efficiency gains.

Ongoing growth in all segments post-ECLGS-5.0. Agri growth constrained by monsoon but risk low. Retail/MSME momentum strong.

Q2 miss (0 bps vs 40–50 bps). FCNR offset repricing. Expected Q3+ via rate cycle 25 bps repricing and FCNR deployment. Unproven.

Rate cycle 25 bps repricing starting Oct. Back-book relief 20–30% coming next 2 Q. Trajectory upward but timing uncertain.

Maintained; productivitygains 10% headcount CAGR, 18–19% volumes. Long-term thesis intact but near-term volatile.

Cost of funds guidance 40-50 bps improvement missed in Q2 (flat at 4.4%). FCNR mix offset repricing gains. If this persists beyond Q3, margin recovery delayed materially.

₹1.3Tr of ₹1.57Tr deposit growth came from special FCNR (B) window (82%). Window likely expires; organic deposit growth much slower. Large one-off outflows from corporates also masked momentum.

Monsoon shortfall (~1.5–2% sowing reduction) could impact agri loan performance. Output variance 3–5% expected. Agri book growth moderated to single-digit (prudent) but risks remain if monsoon extends dry.

Sashidhar Jagdishan (MD for 6 years) leaving; Anup Bagchi (new MD/CEO) to unveil strategy in coming weeks. Implementation risk on margin recovery and growth strategy during transition.

Corporate advances growth 2.8% QoQ (slower vs retail/MSME). Analyst concern that HDFC lags peers on margins. Competition on corporate pricing could pressure margins further.